ALTAO — Aton SA Share News
0.000.00%
Last trade - 00:00- €9.44m
- €14.28m
- €0.66m
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million
Brief: Hybrigenics Signs MoU For Sale Of Block Of Shares Held By DMS
Brief: Hybrigenics Entrusts Inoviem Scientific With R&D Programme
Brief: Hybrigenics' Stemcis Gets FDA Clearance For Medical Devices
Brief: Hybrigenics FY Operating Loss Narrows To 0.1 Million Euros
Brief: Hybrigenics Partners With Business France On Adip'sculpt In U.S.
Brief: Hybrigenics H1 Net Loss Stable At 0.1 Million Euros
Brief: Bone Therapeutics Reacts To Hybrigenics Press Release
Brief: Hybrigenics Renews Proposal For Synergies Discussions With Bone Therapeutics
Brief: Hybrigenics Signs Protocol To Buy Stake In Inoviem Scientific
Brief: Hybrigenics FY Operating Loss Shrinks To 0.3 Million Euros
Brief: DMS Has Set Up EUR 50 Mln SPAC-Inspired Financing Plan
Brief: Hybrigenics Announces 24-Month Financing Through Convertible Bonds Issue
Brief: Hybrigenics H1 Net Loss Narrows At EUR 0.1 Mln
Brief: Hybrigenics Partners With WKK International In Hong Kong
Brief: Hybrigenics: First Favorable Decision In Appeal Against U.S. Patent For USP7 Inhibitors